Clinical Trials Browser

Recruiting × INDUSTRY × Androgen Antagonists × Clear all

NCT06661122 2026-03-19

HAYATE

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT06952803 2026-03-10

EvoPAR-PR02

Phase 3 Recruiting

Prostatic Neoplasms